TNF and neoplasm: ,38,39 vMyx-hTNF was selected for screening because we hypothesized that a generalized immune-enhancing cytokine ligand such as TNF, when preferentially expressed in the context of a tumor bed, might allow increased anti-tumor efficacy compared to unarmed viruses, while avoiding the toxic effects associated with systemic delivery of the purified cytokine.